Piramal plans to put $100 million into niche manufacturing this year while rivals pile into GLP-1, and says it won't go back to drug discovery.
Recap by typeshit. Post by Moneycontrol on X.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Experts walk through what peptides are actually used for, what can go wrong with misuse, and how wellness influencers turned them into a social media trend.
Medscape examines how people on GLP-1 medications can be judged both for their weight and for using a drug to treat it.
Loading…